Company Filing History:
Years Active: 2017
Title: Innovations in Radiopharmaceutical Production: The Contributions of David Patton, Sr.
Introduction
David Patton, Sr. is an accomplished inventor based in Maryville, TN, known for his innovative contributions to the field of radiopharmaceuticals. His pioneering work has led to the development of a novel target assembly designed specifically for the synthesis of radioisotopes, which are essential for various medical applications.
Latest Patents
David Patton, Sr. holds a patent for a "Radioisotope target assembly." This invention features a target assembly designed to produce radioisotopes for use in radiopharmaceuticals. The target assembly comprises a vessel with a chamber that receives target material. Covered by a thin sheet of particle-permeable material, the target chamber is subjected to a bombardment process wherein a high-energy particle beam, generated by a cyclotron or particle accelerator, strikes the cover sheet. This interaction allows particles from the beam to penetrate into the chamber, enabling the alteration of the nuclear composition of the target material to yield valuable radioisotopes.
Career Highlights
David is affiliated with Abt Molecular Imaging, Inc., where he continues to apply his expertise in nuclear engineering and radiochemistry. His career reflects a commitment to advancing medical imaging and therapeutic techniques through innovative technologies.
Collaborations
Throughout his career, David has had the opportunity to collaborate with talented professionals, including Ronald Nutt and Darrell Swicegood. These partnerships have played a significant role in fostering innovation and advancing research in the field of molecular imaging.
Conclusion
David Patton, Sr. exemplifies the spirit of innovation through his substantial contributions to the field of radiopharmaceuticals. His patent for the radioisotope target assembly demonstrates the potential for advancements in medical imaging technology, showcasing how targeted innovations can significantly impact healthcare practices.